Effect of nano-Zataria multiflora supplement on cutaneous candidiasis

Evaluation of antifungal supplement properties of Zataria multiflora-loaded nanostructural lipid carriers on cutaneous candidiasis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210611051539N1

Enrollment

Registered

2021-06-19

Start date

2021-07-06

Completion date

Unknown

Last updated

2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cutaneous candidiasis. Candidiasis of skin and nail

Interventions

Intervention 1: Intervention group: For patients with cutaneous candidiasis (except onychomycosis), 1% thyme nano-gel which is made by Mazandaran University of Medical Sciences in 60 g tubes, is appli

Eligibility

Sex/Gender

All

Age

10 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients presenting with mild-moderate cutaneous candidiasis and do not require treatment with systemic antifungals.

Exclusion criteria

Exclusion criteria: Taking antifungal drugs Children and infants in the age range of 0-10 years

Design outcomes

Primary

Measure	Time frame
Improvement of fungal lesions in terms of mycological criteria. Timepoint: Before the intervention, 2 and 4 weeks after the intervention. Method of measurement: Evaluation of clinical symptoms such as erythema, inflammation and pruritus and evaluation of negative direct examination and mycology culture.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Maryam Moazeni

Mazandaran University of Medical Sciences

moazeni.maryam@gmail.com+98 11 3325 7911

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026